Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732010) titled 'TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)' on July 23.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: NYU Langone Health

Condition: Dry Eye Disease (DED)

Intervention: Drug: TRYPTYR (Acoltremon ophthalmic solution 0.003%)...

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: July 6, 2026

Target Sample Size: 50

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07732010

Disclaimer: Curated ...